We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

JSW:GPWJastrzebska Spolka Weglowa S.A. Analysis

Data as of 2026-05-18 - not real-time

₹270.45

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

JSW Infrastructure is trading around ₹270.45, hugging its 20‑day SMA of ₹275.9 and sitting just above the identified support at ₹256. The RSI sits near the midpoint at 49.7, while the MACD histogram is negative, signaling a bearish short‑term momentum. Valuation metrics are stretched – the forward PE of 23.6 and price‑to‑book of 5.17 sit well above the industry PE average of 29.5, and the DCF fair value of ₹162 implies a ~27.8% upside/downside gap. Recent news of an $850 million share sale adds dilution pressure, potentially widening the valuation gap.
Fundamentally, the company posts solid revenue growth of 18% and impressive operating margins (>40%), yet free cash flow remains negative and debt‑to‑equity is high at 59. Dividend yield is modest at 0.3% with a low payout ratio, but sustainability is questionable given cash constraints. Volatility is elevated (~40% 30‑day), though beta is modest (<0.7), suggesting market‑wide swings rather than stock‑specific risk. Overall, the stock appears overvalued in the near term, but its long‑run infrastructure franchise and growth trajectory keep it on analysts’ radars.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bearish MACD histogram indicating short‑term weakness
  • Proximity to technical support level
  • Upcoming share dilution from $850 M capital raise

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Strong revenue growth and operating margins
  • High valuation relative to DCF and peers
  • Elevated debt load and negative free cash flow

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Long‑run demand for port infrastructure in India
  • Robust operating cash flow generation
  • Strategic capital raise to fund expansion despite current dilution

Key Metrics & Analysis

Financial Health

Revenue Growth17.90%
Profit Margin28.41%
P/E Ratio37.1
ROE13.95%
ROA6.67%
Debt/Equity59.00
P/B Ratio5.2
Op. Cash Flow₹20.2B
Free Cash Flow₹-10984337408
Industry P/E29.5

Technical Analysis

TrendNeutral
RSI49.7
Support₹256.00
Resistance₹295.80
MA 20₹275.89
MA 50₹263.48
MA 200₹281.91
MACDBearish
VolumeIncreasing
Fear & Greed Index89.61

Valuation

Fair Value₹161.97
Target Price₹345.65
Upside/Downside27.80%
GradeOvervalued
TypeGrowth
Dividend Yield0.30%

Risk Assessment

Beta0.67
Volatility40.04%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.